In this episode of My Brain Matters, Stephenie dives into the fascinating world of GLP-1 receptor agonists, medications primarily used for treating type 2 diabetes, and their potential role in alleviating chronic migraines. Discover surprising statistics, hear Stephenie’s personal experience, and learn about the pros and cons of these medications. We also tackle accessibility issues, discussing the high cost and limited insurance coverage for GLP-1 RAs. Tune in for a critical analysis of this emerging treatment option and debunk some common health myths along the way.

References:

- **The Journal of Headache and Pain**: Significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension treated with GLP-1 receptor agonists. Link【BioMed Central】.

- **Frontiers in Endocrinology**: GLP-1 receptor agonists beyond their pancreatic effects, exploring neuroprotective and anti-inflammatory benefits. [Link]【Frontiers】.

- **Frontiers in Pharmacology**: Mechanisms and therapeutic potential of GLP-1 receptor agonists in neuroprotection and reducing inflammation. [Link]【Frontiers】